Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 19% ± 3% |
Insufficient scRNA-seq data for expression of NUDT12 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1020.78 | 653 / 653 | 99% | 20.93 | 601 / 605 |
adrenal gland | 100% | 1443.02 | 258 / 258 | 99% | 16.05 | 228 / 230 |
brain | 100% | 717.62 | 2636 / 2642 | 99% | 19.79 | 700 / 705 |
prostate | 100% | 877.39 | 245 / 245 | 99% | 21.08 | 497 / 502 |
kidney | 100% | 920.26 | 89 / 89 | 99% | 21.00 | 891 / 901 |
pancreas | 100% | 914.31 | 328 / 328 | 97% | 11.27 | 173 / 178 |
breast | 100% | 804.72 | 458 / 459 | 96% | 21.31 | 1073 / 1118 |
esophagus | 100% | 716.72 | 1443 / 1445 | 96% | 10.62 | 175 / 183 |
lung | 98% | 622.89 | 566 / 578 | 95% | 10.42 | 1095 / 1155 |
liver | 100% | 1057.88 | 226 / 226 | 93% | 12.57 | 376 / 406 |
ovary | 99% | 517.96 | 179 / 180 | 92% | 7.52 | 397 / 430 |
uterus | 100% | 598.34 | 170 / 170 | 92% | 8.84 | 421 / 459 |
stomach | 100% | 863.25 | 358 / 359 | 91% | 12.53 | 260 / 286 |
intestine | 100% | 871.43 | 966 / 966 | 89% | 11.93 | 467 / 527 |
bladder | 100% | 713.57 | 21 / 21 | 88% | 9.53 | 443 / 504 |
skin | 100% | 877.85 | 1807 / 1809 | 84% | 8.87 | 398 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.36 | 1 / 1 |
muscle | 100% | 764.74 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 588.93 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 612.86 | 1329 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 401.82 | 236 / 241 | 0% | 0 | 0 / 0 |
heart | 95% | 547.83 | 819 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 7.13 | 39 / 45 |
eye | 0% | 0 | 0 / 0 | 54% | 4.36 | 43 / 80 |
peripheral blood | 16% | 124.42 | 152 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.56 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006734 | Biological process | NADH metabolic process |
GO_0006402 | Biological process | mRNA catabolic process |
GO_0034356 | Biological process | NAD biosynthesis via nicotinamide riboside salvage pathway |
GO_0110156 | Biological process | mRNA methylguanosine-cap decapping |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0006742 | Biological process | NADP catabolic process |
GO_0019677 | Biological process | NAD catabolic process |
GO_0110155 | Biological process | NAD-cap decapping |
GO_0005777 | Cellular component | peroxisome |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990174 | Molecular function | phosphodiesterase decapping endonuclease activity |
GO_0110153 | Molecular function | RNA NAD-cap (NMN-forming) hydrolase activity |
GO_0000210 | Molecular function | NAD+ diphosphatase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0035529 | Molecular function | NADH pyrophosphatase activity |
Gene name | NUDT12 |
Protein name | NAD-capped RNA hydrolase NUDT12 (DeNADding enzyme NUDT12) (EC 3.6.1.-) (NADH pyrophosphatase NUDT12) (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12) (Nudix motif 12) |
Synonyms | |
Description | FUNCTION: mRNA decapping enzyme that specifically removes the nicotinamide adenine dinucleotide (NAD) cap from a subset of mRNAs by hydrolyzing the diphosphate linkage to produce nicotinamide mononucleotide (NMN) and 5' monophosphate mRNA . The NAD-cap is present at the 5'-end of some RNAs; in contrast to the canonical N7 methylguanosine (m7G) cap, the NAD cap promotes mRNA decay . Preferentially acts on NAD-capped transcripts in response to nutrient stress . Also acts on free nicotinamide adenine dinucleotide molecules: hydrolyzes NAD(H) into NMN(H) and AMP, and NADPH into NMNH and 2',5'-ADP . May act to regulate the concentration of peroxisomal nicotinamide nucleotide cofactors required for oxidative metabolism in this organelle . Regulates the levels of circadian clock components PER1, PER2, PER3 and CRY2 in the liver (By similarity). . |
Accessions | ENST00000507423.1 [Q9BQG2-2] ENST00000230792.7 [Q9BQG2-1] Q9BQG2 |